scholarly journals Endovascular treatment of central thoracic venous stenosis and occlusion in hemodialysis patients

2021 ◽  
Vol 12 (12) ◽  
Keyword(s):  
Endovascular Treatment ◽  
Hemodialysis Patients ◽  
Venous Stenosis ◽  
Stenosis And Occlusion

Venous stent versus conventional stent for the treatment of central vein obstruction in hemodialysis patients: a retrospective study

2021 ◽  
pp. 028418512110051
Author(s):  
Surasit Akkakrisee ◽  
Keerati Hongsakul
Keyword(s):  
Endovascular Treatment ◽  
Patency Rate ◽  
Demographic Data ◽  
Hemodialysis Patients ◽  
Primary Patency ◽  
Central Vein ◽  
Primary Patency Rate ◽  
Patient Demographic Data ◽  
Upper Thoracic ◽  
Vein Stenosis

Background Endovascular treatment is a first-line treatment for upper thoracic central vein obstruction (CVO). Few studies using bare venous stents (BVS) in CVO have been conducted. Purpose To evaluate the treatment performance of upper thoracic central vein stenosis between BVS and conventional bare stent (CBS) in hemodialysis patients. Methods Hemodialysis patients with upper thoracic central vein obstruction who underwent endovascular treatment at the interventional unit of our institution from 1 January 2008 to 31 December 2018 were enrolled in the present study. CBS was used to treat central vein obstruction in 43 patients and BVS in 34 patients. We compared the primary patency rates and complications between the two stent types. P values < 0.05 were considered statistically significant. Results The patient demographic data between the CBS and BVS groups were similar. The characteristics of the lesions, procedures, and complications were not significantly different between the two groups ( P > 0.05). There were no statistically significant differences of primary patency rates at three and six months between the BVS and CBS groups (94.1% vs. 86.0% and 73.5% vs. 58.1%, respectively; P > 0.05). The primary patency rate at 12 months in the BVS group was significantly higher than that in the CBS group (61.8% vs. 32.6%; P = 0.008). Conclusion Endovascular treatment of central vein obstruction with BVS provided a higher primary patency rate at 12 months than CBS.

Endovascular Treatment of Central Vein Stenoses and/or Occlusions in Hemodialysis Patients

2003 ◽  
Vol 26 (1) ◽  
pp. 27-30 ◽  
Author(s):  
Jana Maskov� ◽  
Jana Kom�rkov� ◽  
Ji?� Kiv�nek ◽  
Jan Danes ◽  
Marcela Slav�kov�
Keyword(s):  
Endovascular Treatment ◽  
Hemodialysis Patients ◽  
Central Vein

Stent-Graft Length Is Associated with Decreased Patency in Treatment of Central Venous Stenosis in Hemodialysis Patients

2019 ◽  
Vol 59 ◽  
pp. 225-230 ◽  
Author(s):  
Mina L. Boutrous ◽  
Alejandro C. Alvarez ◽  
Obi T. Okoye ◽  
Jennifer C. Laws ◽  
Donald L. Jacobs ◽  
...  
Keyword(s):  
Stent Graft ◽  
Hemodialysis Patients ◽  
Central Venous ◽  
Central Venous Stenosis ◽  
Venous Stenosis ◽  
Graft Length

scholarly journals Radiation-associated venous stenosis: endovascular treatment options

2004 ◽  
Vol 40 (1) ◽  
pp. 179-182 ◽  
Author(s):  
Wei Zhou ◽  
Ruth L Bush ◽  
Peter H Lin ◽  
Alan B Lumsden
Keyword(s):  
Endovascular Treatment ◽  
Treatment Options ◽  
Venous Stenosis

Patency of Endovascular Treatment for Central Venous Stenosis: Is There a Difference Between Dialysis Fistulas and Grafts?

2007 ◽  
Vol 18 (3) ◽  
pp. 353-359 ◽  
Author(s):  
Dheeraj K. Rajan ◽  
S. Murthy Chennepragada ◽  
Charmaine E. Lok ◽  
J. Robert Beecroft ◽  
Kong T. Tan ◽  
...  
Keyword(s):  
Endovascular Treatment ◽  
Central Venous ◽  
Central Venous Stenosis ◽  
Venous Stenosis
Sign in / Sign up

Export Citation Format

Share Document